Kite, a Gilead company, invites you to join a Nordic online webinar series throughout Spring 2026 exploring the evolving standards of care in DLBCL and MCL.
Through expert-led sessions across the season, the series will focus on how emerging evidence – particularly in CAR T cell therapy – is translating into clinical practice. Join to gain practical insights, deepen your understanding of current treatment strategies, and support informed decision-making across the patient journey.
Please select the webinars below that you would like to sign up for.
March 10
Speaker: Dr Andrea Kuhnl, Consultant Hematologist, King's College Hospital NHS Foundation Trust, London
Moderator: Dr Per-Ola Andersson, Senior Consultant and Professor, Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg
April 17
Speaker: Dr Georg Heß, Professor Department of Hematology and Oncology, University Medical School of the Johannes Gutenberg-University
Moderator: Dr Ingrid Glimelius Senior Consultant and Professor Department of Immunology, Genetics and Pathology, Uppsala University
May 27
Speaker: Dr Eleni Tholouli, Consultant Haematologist & Haemo-Oncologist, Manchester Royal Infirmary, Manchester
Moderator: Dr Tomas Stauffer Larsen, Professor, Consultant, PhD, Department of Hematology, Odense University Hospital, Denmark